Health Canada drug identification number

DIN 02550458 — KETAMINE HYDROCHLORIDE INJECTION, USP 50 MG

KETAMINE HYDROCHLORIDE INJECTION, USP is a solution of Ketamine marketed by FRESENIUS KABI CANADA LTD. The full Ketamine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02550458
Brand name
KETAMINE HYDROCHLORIDE INJECTION, USP
Active ingredient
Ketamine
Strength
50 MG
Dosage form
SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Manufacturer
FRESENIUS KABI CANADA LTD
Health Canada status
MARKETED
Drug class
Parenteral general anesthetic (dissociative anesthetic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Ketamine products

DINBrandStrengthFormManufacturerStatus
00224391 KETALAR 10 MG SOLUTION SEARCHLIGHT PHARMA INC MARKETED
00224405 KETALAR 50 MG SOLUTION SEARCHLIGHT PHARMA INC MARKETED
02246795 KETAMINE HYDROCHLORIDE INJECTION USP 10 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02246796 KETAMINE HYDROCHLORIDE INJECTION USP 50 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02550431 KETAMINE HYDROCHLORIDE INJECTION, USP 10 MG SOLUTION FRESENIUS KABI CANADA LTD MARKETED
02535645 KETAMINE INJECTION, BP 50 MG SOLUTION STERIMAX INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.